Allison Martell

Canadian drug price regulator may be flexible on rare diseases

13 Aug 2019

TORONTO Canada's patented drug price regulator, set to gain new powers next year, may be "more forgiving" in setting price caps for drugs that treat rare diseases, the agency's executive director told Reuters, as some advocates warned the country's pricing reforms would hurt patients.

Canada enacts drug price crackdown, in blow to pharmaceutical industry

10 Aug 2019

TORONTO The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices that are among the highest in the world, overcoming heavy opposition from pharmaceutical companies who may eventually challenge the new rules in court.

Drug industry urges Canada to act early on U.S. import plan

05 Aug 2019

TORONTO Canada's main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents seen by Reuters.

Exclusive: Two powerful Canadian provinces argued against federal drug price crackdown

31 Jul 2019

TORONTO/MONTREAL Canada's two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan to slash the price of patented drugs, arguing that such regulatory changes could hurt investment in life sciences.

Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns

19 Jul 2019

TORONTO Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country's drug supply or raise costs for its own citizens, officials have told U.S. authorities, in a new setback to the Trump administration's efforts to tackle high drug prices, according to documents obtained by Reuters.

Canadian panel calls for universal public drug coverage

13 Jun 2019

OTTAWA/TORONTO A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create a C$15.3 billion ($11.5 billion) universal, single-payer public pharmacare system, and warned that the current system requires a major overhaul.

Exclusive: Canada told drugmakers it would limit scope of some new price rules

30 May 2019

TORONTO The Canadian government has assured the pharmaceutical industry that new features of its plan to cut drug costs would apply only to new medicines, Health Canada said, offering some relief to drugmakers even as other regulations could still lower prices of medicines already on the market.

UPDATE 3-British Columbia to be first Canadian province to switch patients to biosimilars

28 May 2019

TORONTO/MONTREAL, May 27 The Canadian province of British Columbia said on Monday that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to cheap near-copies called biosimilars, saving an estimated C$96.6 million ($71.9 million)over three years.

Ex-ministers who quit Trudeau government will run as independents in Canadian election

27 May 2019

MARKHAM, Ontario Two former ministers who quit Canadian Prime Minister Justin Trudeau's government this year over his handling of a scandal said on Monday they would run as independents in an election this October.

World News